table of content
1 Introduction to Research & Analysis Reports
1.1 Targeted Small Molecule Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Small Molecule Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Small Molecule Therapy Overall Market Size
2.1 Global Targeted Small Molecule Therapy Market Size: 2022 VS 2029
2.2 Global Targeted Small Molecule Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Small Molecule Therapy Players in Global Market
3.2 Top Global Targeted Small Molecule Therapy Companies Ranked by Revenue
3.3 Global Targeted Small Molecule Therapy Revenue by Companies
3.4 Top 3 and Top 5 Targeted Small Molecule Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Targeted Small Molecule Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Small Molecule Therapy Players in Global Market
3.6.1 List of Global Tier 1 Targeted Small Molecule Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Small Molecule Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeted Small Molecule Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Targeted Small Molecule Therapy Revenue & Forecasts
4.2.1 By Type - Global Targeted Small Molecule Therapy Revenue, 2018-2023
4.2.2 By Type - Global Targeted Small Molecule Therapy Revenue, 2024-2029
4.2.3 By Type - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Small Molecule Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Small Molecule Therapy Revenue & Forecasts
5.2.1 By Application - Global Targeted Small Molecule Therapy Revenue, 2018-2023
5.2.2 By Application - Global Targeted Small Molecule Therapy Revenue, 2024-2029
5.2.3 By Application - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Targeted Small Molecule Therapy Market Size, 2022 & 2029
6.2 By Region - Global Targeted Small Molecule Therapy Revenue & Forecasts
6.2.1 By Region - Global Targeted Small Molecule Therapy Revenue, 2018-2023
6.2.2 By Region - Global Targeted Small Molecule Therapy Revenue, 2024-2029
6.2.3 By Region - Global Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Targeted Small Molecule Therapy Revenue, 2018-2029
6.3.2 US Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.3 Canada Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.4 Mexico Targeted Small Molecule Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Targeted Small Molecule Therapy Revenue, 2018-2029
6.4.2 Germany Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.3 France Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.4 U.K. Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.5 Italy Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.6 Russia Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.8 Benelux Targeted Small Molecule Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Targeted Small Molecule Therapy Revenue, 2018-2029
6.5.2 China Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.3 Japan Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.4 South Korea Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.6 India Targeted Small Molecule Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Targeted Small Molecule Therapy Revenue, 2018-2029
6.6.2 Brazil Targeted Small Molecule Therapy Market Size, 2018-2029
6.6.3 Argentina Targeted Small Molecule Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Small Molecule Therapy Revenue, 2018-2029
6.7.2 Turkey Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.3 Israel Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.5 UAE Targeted Small Molecule Therapy Market Size, 2018-2029
7 Targeted Small Molecule Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Targeted Small Molecule Therapy Major Product Offerings
7.1.4 Bayer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Targeted Small Molecule Therapy Major Product Offerings
7.2.4 Eisai Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Targeted Small Molecule Therapy Major Product Offerings
7.3.4 Zelgen Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Targeted Small Molecule Therapy Major Product Offerings
7.4.4 Cipla Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Targeted Small Molecule Therapy Major Product Offerings
7.5.4 Natco Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Targeted Small Molecule Therapy Major Product Offerings
7.6.4 AstraZeneca Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Targeted Small Molecule Therapy Major Product Offerings
7.7.4 Novartis Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Targeted Small Molecule Therapy Major Product Offerings
7.8.4 Roche Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Small Molecule Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Targeted Small Molecule Therapy Major Product Offerings
7.10.4 Pfizer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Targeted Small Molecule Therapy Major Product Offerings
7.11.4 BEACON Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Targeted Small Molecule Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Targeted Small Molecule Therapy Major Product Offerings
7.13.4 Yao Pharma Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Targeted Small Molecule Therapy Major Product Offerings
7.14.4 CSPC Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Targeted Small Molecule Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Targeted Small Molecule Therapy Major Product Offerings
7.16.4 Simcere Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
